Study guide

4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm)

IBSC CCP-C Certified Critical Care Paramedic Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Strategy

1.1 About the CCP-C Exam 1.2 CCP-C Study Strategy & Exam Tactics

2 Chapter 2: Transport and Safety (Part 1)

2.1 Crew Resource Management & Sterile Cockpit Rule 2.2 Transport Risk Assessment & Mission Decision-Making 2.3 Aircraft and Ground Transport Safety Protocols

3 Chapter 2: Transport and Safety (Part 2)

2.4 Environmental Transport Stressors & Gas Laws 2.5 Transport Equipment Management & Post-Mission Operations

4 Chapter 3: Airway, Anesthesia, and Analgesics (Part 1)

3.1 Advanced Airway Assessment & Difficult Airway Identification 3.2 Rapid Sequence Induction (RSI) - Pretreatment & Induction Agents 3.3 Neuromuscular Blockade - Depolarizing vs Non-Depolarizing Agents 3.4 Post-Intubation Sedation, Analgesia & Dissociative Maintenance 3.5 Transport Ventilator Setup & Primary Ventilation Modes

5 Chapter 3: Airway, Anesthesia, and Analgesics (Part 2)

3.6 Mechanical Ventilator Waveforms, Loops & Oxygenation Titration 3.7 Ventilator Alarm Troubleshooting & Peak vs Plateau Pressures 3.8 Rescue Airway Devices, Video Laryngoscopy & Surgical Cricothyrotomy 3.9 Neuromuscular Reversal & Vasoactive Airway Support 3.10 Transport Airway Management in Unique Environments & Extubation

6 Chapter 4: General Medical Patient

4.1 Sepsis, Severe Sepsis & Septic Shock Resuscitation 4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm) 4.3 Renal and Hepatic Emergencies in Transport

7 Chapter 5: Cardiac Patient

5.1 Acute Coronary Syndromes & Infarct Specific Complications 5.2 Invasive Hemodynamic Monitoring 5.3 Vasoactive & Inotropic Medication Titration 5.4 Mechanical Circulatory Support & Post-Cardiac Arrest Care

8 Chapter 6: Neurological Patient

6.1 Traumatic Brain Injury & Intracranial Pressure (ICP) Management 6.2 Acute Ischemic Stroke, Hemorrhagic Stroke & Subarachnoid Hemorrhage 6.3 Status Epilepticus, Spinal Cord Injury & Neurogenic Shock

9 Chapter 7: Respiratory Patient

7.1 Acute Respiratory Distress Syndrome (ARDS) & Lung-Protective Ventilation 7.2 Severe Asthma & COPD Exacerbations in Critical Care 7.3 Chest Tube Management, Pleural Drains & Tension Pneumothorax 7.4 Pulmonary Embolism, Pulmonary Hypertension & Transport Respiratory Meds

10 Chapter 8: Toxic Exposure and Environmental Patient

8.1 Toxicology Emergencies, Toxidromes & Antidote Therapy 8.2 Environmental Emergencies (Hypothermia, Hyperthermia, Frostbite) 8.3 Submersion, Diving Emergencies & Envenomation/HazMat

11 Chapter 9: Trauma and Burn Patient

9.1 Hemorrhagic Shock Resuscitation & Massive Transfusion Protocols (MTP) 9.2 Severe Thoracic & Abdominal Trauma Management 9.3 Thermal, Chemical & Electrical Burn Assessment & Fluid Resuscitation 9.4 Musculoskeletal Trauma, Pelvic Fractures & Compartment Syndrome

12 Chapter 10: Maternal and Fetal Medicine

10.1 High-Risk Obstetric Assessment & Hypertensive Disorders of Pregnancy 10.2 Obstetric Hemorrhage, Placental Abruption & Preterm Labor 10.3 Emergency Transport Delivery, Umbilical Cord Prolapse & Fetal Monitoring

13 Chapter 11: Pediatric Patient

11.1 Pediatric Critical Care Airway & Transport Ventilation 11.2 Pediatric Shock, Dehydration & Weight-Based Dosing 11.3 Neonatal Resuscitation Program (NRP) & Transport of the Critical Neonate

14 Chapter 12: Special Populations

12.1 Bariatric Critical Care Transport & Positional Management 12.2 Geriatric Critical Care & Patients with Specialized Medical Technology

15 Chapter 13: Professional Considerations

13.1 Legal Aspects, EMTALA & Transport Ethics 13.2 Quality Improvement, Transport Safety Research & Evidence-Based Practice

4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm)

Key Takeaways Explain This Topic AI

DKA (2024 adult consensus) is characterized by glucose ≥ 200 mg/dL or known diabetes (about 10% are euglycemic), metabolic acidosis (pH < 7.30 and/or bicarb < 18 mEq/L), usually a high anion gap, and elevated serum ketones, whereas HHS presents with severe hyperglycemia (> 600 mg/dL), serum osmolality > 320 mOsm/kg, and minimal acidosis.

Potassium replacement is mandatory prior to initiating insulin therapy; if serum K+ is < 3.5 mEq/L, insulin must be withheld until potassium is restored to > 3.5 mEq/L (2024 adult consensus).

Regular insulin is infused at 0.1 units/kg/hr; once glucose falls below 250 mg/dL in DKA (or 300 mg/dL in HHS), 5-10% dextrose must be added to IV fluids while maintaining insulin to clear ketoacidosis.

Rapid drop in serum osmolality increases the risk of fatal cerebral edema; serum glucose reduction must be limited to 50-75 mg/dL/hr.

Thyroid storm treatment requires a precise sequential medical strategy: Beta-blocker -> PTU/Methimazole -> Iodine (at least 1 hour post-PTU) -> Hydrocortisone.

Last updated: October 2026

  • 4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm)
  • Diabetic Ketoacidosis (DKA) vs. Hyperosmolar Hyperglycemic State (HHS)

Diabetic Ketoacidosis ( DKA ) and Hyperosmolar Hyperglycemic State ( HHS ) represent extreme decompensations of diabetes mellitus. While both involve insulin dysfunction and severe hyperglycemia, their underlying pathophysiology, biochemical markers, and clinical presentations differ markedly.

Pathophysiology & Diagnostic Criteria

DKA : Results from an absolute deficiency of insulin combined with an excess of counter-regulatory hormones (glucagon, catecholamines, cortisol, growth hormone). This shifts cellular metabolism to lipolysis, generating free fatty acids converted by the liver into ketone bodies ( β \beta β -hydroxybutyrate and acetoacetate). This produces metabolic acidosis with an elevated anion gap ( > 10 − 12 mEq/L > 10-12\text{ mEq/L} > 10 − 12 mEq/L , calculated as [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) [ Na + ] − ([ Cl − ] + [ HCO 3 − ​ ]) ).

HHS : Results from a relative insulin deficiency . There is sufficient circulating insulin to prevent significant lipolysis and ketogenesis, but insufficient insulin to facilitate peripheral glucose uptake. Consequently, extreme hyperglycemia develops, producing massive osmotic diuresis, profound dehydration, and serum hyperosmolality ( > 320 mOsm/kg > 320\text{ mOsm/kg} > 320 mOsm/kg ).

Diagnostic Matrix: DKA vs. HHS

Diagnostic Parameter Mild DKA Moderate DKA Severe DKA Hyperosmolar Hyperglycemic State (HHS)

Blood Glucose ≥ 200 mg/dL \geq 200\text{ mg/dL} ≥ 200 mg/dL or known diabetes ≥ 200 mg/dL \geq 200\text{ mg/dL} ≥ 200 mg/dL or known diabetes ≥ 200 mg/dL \geq 200\text{ mg/dL} ≥ 200 mg/dL or known diabetes > 600 mg/dL > 600\text{ mg/dL} > 600 mg/dL (often > 1000 mg/dL > 1000\text{ mg/dL} > 1000 mg/dL )

Arterial/Venous pH 7.25 − 7.30 7.25 - 7.30 7.25 − 7.30 7.00 − 7.24 7.00 - 7.24 7.00 − 7.24 < 7.00 < 7.00 < 7.00 > 7.30 > 7.30 > 7.30

Serum Bicarbonate 15 − 18 mEq/L 15 - 18\text{ mEq/L} 15 − 18 mEq/L 10 − < 15 mEq/L 10 - < 15\text{ mEq/L} 10 − < 15 mEq/L < 10 mEq/L < 10\text{ mEq/L} < 10 mEq/L > 18 mEq/L > 18\text{ mEq/L} > 18 mEq/L

  • Urine/Serum Ketones Positive Positive Positive Negative or trace
  • Serum Osmolality Variable Variable Variable > 320 mOsm/kg > 320\text{ mOsm/kg} > 320 mOsm/kg

Anion Gap > 10 mEq/L > 10\text{ mEq/L} > 10 mEq/L > 12 mEq/L > 12\text{ mEq/L} > 12 mEq/L > 12 mEq/L > 12\text{ mEq/L} > 12 mEq/L Variable (usually normal < 12 < 12 < 12 )

  • Mental Status Alert Alert / Drowsy Stupor / Coma Stupor / Coma
  • Fluid Resuscitation & Glucose Titration

Fluid replacement is the initial therapeutic priority to restore intravascular volume, improve renal perfusion, and reduce serum glucose through dilution.

Initial Fluid Resuscitation : Infuse 0.9 % 0.9\% 0.9% Normal Saline or a balanced crystalloid at 500 − 1,000 mL/hr 500 - 1{,}000\text{ mL/hr} 500 − 1 , 000 mL/hr for the first 2-4 hours in adults without renal or cardiac compromise (smaller 250 mL boluses in older adults, heart failure, or dialysis).

Subsequent Fluid Selection : Calculate corrected sodium ( [ Na + ] corrected = [ Na + ] measured + 0.016 × ( Glucose − 100 ) [\text{Na}^+]_{\text{corrected}} = [\text{Na}^+]_{\text{measured}} + 0.016 \times (\text{Glucose} - 100) [ Na + ] corrected ​ = [ Na + ] measured ​ + 0.016 × ( Glucose − 100 ) ):

If corrected Na + \text{Na}^+ Na + is normal or high, switch to 0.45 % 0.45\% 0.45% Normal Saline at 250 − 500 mL/hr 250 - 500\text{ mL/hr} 250 − 500 mL/hr .

If corrected Na + \text{Na}^+ Na + is low, continue 0.9 % 0.9\% 0.9% Normal Saline at 250 − 500 mL/hr 250 - 500\text{ mL/hr} 250 − 500 mL/hr .

Dextrose Addition : When blood glucose falls below 250 mg/dL 250\text{ mg/dL} 250 mg/dL in DKA (or 300 mg/dL 300\text{ mg/dL} 300 mg/dL in HHS ), add 5 % 5\% 5% or 10 % 10\% 10% Dextrose ( D 5 W D_5W D 5 ​ W or D 5 0.45 % D_5 0.45\% D 5 ​ 0.45% NS) to IV fluids. Do not stop the insulin drip at this stage! Dextrose co-infusion allows continuous insulin administration to suppress ketoacidosis while preventing hypoglycemia.

Critical Potassium Replacement Rules

Insulin drives potassium from the extracellular space into cells via N a + / K + Na^+/K^+ N a + / K + ATPase activation. Administering insulin during severe hypokalemia causes precipitous shifts leading to lethal cardiac arrhythmias or respiratory muscle paralysis.

Mandatory Potassium Rules Prior to Insulin Drip

If Serum K + < 3.5 mEq/L \text{K}^+ < 3.5\text{ mEq/L} K + < 3.5 mEq/L : HOLD INSULIN THERAPY! Administer KCl \text{KCl} KCl about 10 mEq/hr 10\text{ mEq/hr} 10 mEq/hr IV until serum potassium exceeds 3.5 mEq/L 3.5\text{ mEq/L} 3.5 mEq/L (2024 adult consensus). Only then may insulin be initiated.

If Serum K + = 3.5 − 5.0 mEq/L \text{K}^+ = 3.5 - 5.0\text{ mEq/L} K + = 3.5 − 5.0 mEq/L : Initiate insulin infusion AND add 20 − 30 mEq KCl 20 - 30\text{ mEq } \text{KCl} 20 − 30 mEq KCl per liter of IV fluid to maintain serum potassium between 4.0 − 5.0 mEq/L 4.0 - 5.0\text{ mEq/L} 4.0 − 5.0 mEq/L .

If Serum K + > 5.0 mEq/L \text{K}^+ > 5.0\text{ mEq/L} K + > 5.0 mEq/L : Initiate insulin infusion without IV potassium; recheck serum K + \text{K}^+ K + 2 hours after insulin starts, then every 4 hours, and add potassium once it falls below 5.0 mEq/L 5.0\text{ mEq/L} 5.0 mEq/L .

Insulin Infusion Dosing

Administer Regular Insulin as a continuous IV infusion at 0.1 units/kg/hr 0.1\text{ units/kg/hr} 0.1 units/kg/hr (or 0.14 units/kg/hr 0.14\text{ units/kg/hr} 0.14 units/kg/hr without an initial bolus). Target a rate of glucose decline of 50 − 75 mg/dL per hour 50 - 75\text{ mg/dL per hour} 50 − 75 mg/dL per hour .

Cerebral Edema Risk & Prevention

Rapid decreases in serum glucose and effective osmolality create an osmotic gradient across the blood-brain barrier, driving water into brain cells and causing acute cerebral edema . Cerebral edema is a major cause of mortality during DKA/HHS treatment, particularly in pediatric and young adult populations.

Prevention : Limit the rate of glucose reduction to < 75 − 100 mg/dL/hr < 75-100\text{ mg/dL/hr} < 75 − 100 mg/dL/hr and effective osmolality reduction to < 3 mOsm/kg/hr < 3\text{ mOsm/kg/hr} < 3 mOsm/kg/hr .

Clinical Warning Signs : New-onset headache, lethargy, bradycardia and hypertension (Cushing's triad), confusion, or decreased GCS score during transport.

Immediate Treatment : Administer Mannitol ( 0.5 − 1.0 g/kg 0.5 - 1.0\text{ g/kg} 0.5 − 1.0 g/kg IV over 15 min) or 3 % 3\% 3% Hypertonic Saline ( 2.5 − 5.0 mL/kg 2.5 - 5.0\text{ mL/kg} 2.5 − 5.0 mL/kg IV over 10-15 min) . Elevate head of bed 30 ∘ 30^\circ 3 0 ∘ .

Acute Adrenal Crisis

Acute adrenal crisis is a life-threatening endocrine emergency resulting from an absolute deficiency of glucocorticoids (cortisol) and mineralocorticoids (aldosterone). It occurs in patients with primary adrenal insufficiency (Addison's disease) or secondary adrenal failure (hypothalamic-pituitary axis suppression) exposed to physiological stress (infection, trauma, surgery, or abrupt steroid withdrawal).

  • Clinical Manifestations
  • Refractory hypotension and vasopressor-resistant shock
  • Severe abdominal pain, fever, nausea, vomiting

Biochemical hallmarks: Hyponatremia , Hyperkalemia , Hypoglycemia , and non-anion gap metabolic acidosis.

Transport Management Protocol

Steroid Replacement : Administer Hydrocortisone 100 mg 100\text{ mg} 100 mg IV push immediately, followed by 100 − 200 mg 100-200\text{ mg} 100 − 200 mg over 24 hours (or 50 mg 50\text{ mg} 50 mg IV Q6H). Hydrocortisone provides both glucocorticoid and mineralocorticoid coverage.

Alternative : If formal cosyntropin stimulation testing is planned post-transport, administer Dexamethasone 4 mg 4\text{ mg} 4 mg IV push , as it does not cross-react with cortisol assays.

Volume & Glucose Resuscitation : Rapidly infuse D 5 N S D_5NS D 5 ​ NS crystalloid boluses to restore intravascular volume and correct hypoglycemia.

Thyroid Storm (Thyrotoxic Crisis)

Thyroid storm is an extreme, life-threatening manifestation of thyrotoxicosis characterized by hypermetabolism and systemic decompensation. Triggers include infections, trauma, surgery, or iodine exposure in patients with underlying Graves' disease or toxic multinodular goiter.

Clinical Manifestations

Hyperthermia : Extreme fever ( > 40.0 ∘ C / 104.0 ∘ F > 40.0^\circ\text{C} / 104.0^\circ\text{F} > 40. 0 ∘ C /104. 0 ∘ F ).

Cardiovascular : Severe tachycardia, high-output heart failure, atrial fibrillation with rapid ventricular response.

Central Nervous System : Extreme agitation, delirium, psychosis, or coma.

Gastrointestinal : Diarrhea, jaundice, abdominal pain.

Four-Step Sequential Blockade Protocol for Thyroid Storm

Pharmacological management of thyroid storm requires a strict multi-drug strategy executed in a precise order:

Step Drug & Dosage Pharmacological Mechanism Clinical Rationale

1. Beta-Blocker Propranolol : 1 − 2 mg 1 - 2\text{ mg} 1 − 2 mg slow IV push (or 60 − 80 mg 60-80\text{ mg} 60 − 80 mg PO Q6H) Blocks β 1 / β 2 \beta_1/\beta_2 β 1 ​ / β 2 ​ receptors; inhibits peripheral conversion of T 4 → T 3 T_4 \rightarrow T_3 T 4 ​ → T 3 ​ Controls hyperadrenergic state (tachycardia, fever)

2. Antithyroid Synthesis Inhibitor Propylthiouracil (PTU) : 200 − 400 mg 200-400\text{ mg} 200 − 400 mg PO/NG Q6H (or Methimazole 20 mg 20\text{ mg} 20 mg PO Q6H) Inhibits thyroid peroxidase, blocking new hormone synthesis PTU also blocks peripheral conversion of T 4 → T 3 T_4 \rightarrow T_3 T 4 ​ → T 3 ​

3. Iodine Administration Potassium Iodide (SSKI) : 5 drops PO Q6H (Give ≥ 1 hour \ge 1\text{ hour} ≥ 1 hour AFTER Step 2) Blocks release of preformed hormone (Wolff-Chaikoff effect) Must give AFTER Step 2 to prevent iodine from fueling new synthesis

4. Glucocorticoids Hydrocortisone : 100 mg 100\text{ mg} 100 mg IV Q8H (or Dexamethasone 2 mg 2\text{ mg} 2 mg IV Q6H) Inhibits T 4 → T 3 T_4 \rightarrow T_3 T 4 ​ → T 3 ​ conversion; treats relative adrenal exhaustion Protects against co-existing adrenal insufficiency

Critical Caution : When managing fever in thyroid storm, AVOID ASPIRIN / SALICYLATES . Salicylates displace thyroid hormones ( T 3 / T 4 T_3/T_4 T 3 ​ / T 4 ​ ) from thyroid-binding globulin (TBG), dramatically raising free serum thyroid hormone levels and worsening the crisis. Use Acetaminophen and active cooling blankets.